Karen Holt. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/pharmacologyBevacizumabCamptothecin/administration & dosageCamptothecin/adverse effectsCamptothecin/analogs & derivativesCapecitabineCetuximabColorectal Neoplasms/drug therapyComplementary Therapies/adverse effectsDeoxycytidine/administration & dosageDeoxycytidine/adverse effectsDeoxycytidine/analogs & derivativesDrug InteractionsFluorouracil/administration & dosageFluorouracil/adverse effectsFluorouracil/analogs & derivativesHumansIrinotecanLeucovorin/administration & dosageLeucovorin/adverse effectsOrganoplatinum Compounds/administration & dosageOrganoplatinum Compounds/adverse effectsOxaliplatinPanitumumab
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedOrganoplatinum CompoundsOxaliplatinDeoxycytidineBevacizumabCapecitabinePanitumumabIrinotecanCetuximabLeucovorinFluorouracilCamptothecin
Year: 2011 PMID: 21751717
Source DB: PubMed Journal: J Pract Nurs ISSN: 0022-3867